Article Text

other Versions

Bleeding during percutaneous intervention - Tailoring the approach to minimise risk
  1. Timothy Kinnaird (tim.kinnaird{at}
  1. University Hospital Wales, United Kingdom
    1. Richard Anderson (richard.anderson{at}
    1. University Hospital Wales, United Kingdom
      1. Jonathan Hill (jonathan.hill{at}
      1. Kings College Hospital, United Kingdom
        1. Martyn Thomas (mttwins{at}
        1. Kings College Hospital, United Kingdom


          Introduction The incidence of ischaemic complications during percutaneous intervention (PCI) has reduced over recent years. The routine use of stents, ever-improving adjunctive pharmacology, and devices such as rotablation, intra-aortic balloon pumps and aspiration catheters have all served to optomise distal perfusion and minimise ischaemic complications. As a result major bleeding has now emerged as one of the most common complications of PCI in contemporary practice. In addition, measures intended to minimise ischaemic complications may actually increase bleeding risk. Recent studies have highlighted not only the frequency with which major bleeding occurs but demonstrated the importance of bleeding on short and medium-term outcomes. As such bleeding can no longer be considered an irritation that can simply be ignored or transfused.

          • Access site
          • Adjunctive pharmacotherapy
          • Bleeding
          • Complications
          • PCI

          Statistics from

          Request permissions

          If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.